4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-19-007343
Options or other derivatives
- Chief Executive Officer acquired 393,041 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| FOUSE JACQUALYN A Chief Executive Officer | 2019-02-01 | Grant or award · Stock option (right to buy) | +350,346 | 350,346 | D | ||
| FOUSE JACQUALYN A Chief Executive Officer | 2019-02-01 | Grant or award · Performance share units | +42,695 | 42,695 | D | ||
Loading xslF345X03/doc4.xml…